U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 6055910

/patents/6055910.html

A gun that fires a missile, powered by gas "discharged by the operator of the toy."

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 514/368 - Ring nitrogen is shared by the cyclos of the bicyclo ring system (e.g., tetramisole, etc.)


Subclass of Class 514 - Drug, bio-affecting and body treating compositions
Definition: Subject matter wherein the ring nitrogen is a member of
No. of patents: 147
Last issue date: 03/20/2012


1        
NumberTitleIssue Date
8138210Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
The present invention refers to new indanyl sulphonamide compounds with general formula (I), as well as to their preparation procedure, their application as medicine and the pharmaceuticals composition which they are made up of. ...
03/20/2012
8080569Imidazo[2,1-b]thiazoles and their use as pharmaceuticals
The present invention relates to derivatives of imidazo[2,1-b]thiazoles of formula I, in which R, R1 to R3 and n have the meanings indicated in the claims, which modulate the transcription of endothelial nitric oxide (NO) s...
12/20/2011
7671078Isothiourea derivatives of imadazo[2,1-b]Thiazoles and 5,6-dihydro derivatives thereof useful as CXCR4 chemokine receptor inhibitors
The invention relates to isothiourea derivatives of formula I: wherein R1 is a residue of one of the following structures: where the variables are as defined in the cla...
03/02/2010
7662841Imidazothiazole derivatives and process for producing the same
The present invention relates to compounds of formula (I) and a process for producing the same. In formula (I), X represents a halogen atom, and R1 represents group —COR2 wherein R2 represents group OM or C1-12 alkyloxy wherein M r...
02/16/2010
7419993Triazolo-epothilones
The invention relates to triazolo-thiazole analogues of epothilone A and epothilone B. ...
09/02/2008
7351481Imidazole ring-containing compound and organic electroluminescence display device
The present invention is related to an imidazole ring-containing compound and an organic electroluminescence (EL) display device using the same. In particular, the imidazole ring-containing compound may be used alone or in combination with a dopant as a material for...
04/01/2008
7351732Cycloalkanedione derivatives, method for the production thereof and their pharmacological applications
New cycloalkanedione derivatives that are serotonin (5-hydroxytriptamine, 5-HT) 5-HT1A receptor subtype agonists and, consequently, they are useful in the treatment of pathological states for which an agonist of these receptors is indicated. They a...
04/01/2008
7345069Oxidative activation and episulfonium ion-mediated DNA alkylation-based anticancer
The present invention relates to TG-25 and/or analogs thereof and their use of TG-25 in the treatment of cancer. TG-25 inhibits the growth of prostate cells by inhibiting DNA synthesis, more particularly by DNA cleavage. ...
03/18/2008
7288559Carboxamide spirohydantoin CGRP receptor antagonists
The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pha...
10/30/2007
7230021Potent, simplified derivatives of pateamine A
The present invention provides a compound of Formula I, all of its related stereoisomers, and their pharmaceutically acceptable salts, wherein A—B, K, Q, X, Y, Z, R and R1 are as defined in Claim 1. The present invention also provides processes for the prep...
06/12/2007
7220756N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of a CNS disorder relating to or affected by the 5-HT6 receptor ...
05/22/2007
7214802Anti-cytokine heterocyclic compounds
Disclosed compounds of formula (I) which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chr...
05/08/2007
7172767Opioid agonist / antagonist combinations
The invention is directed in part to oral dosage forms comprising a combination of an orally analgesically effective amount of an opioid agonist and an orally active opioid antagonist, the opioid antagonist being included in a ratio to the opioid agonist to provide ...
02/06/2007
7173013Treatment of tuberculosis using immunomodulator compounds
Tuberculosis in an animal is treated by administration of a therapeutically effective amount of an immunomodulator of formula A. In formula (A), n is 1 or 2, R is hydrogen, acyl, alkyl or a peptide fragment, and X is an aromatic or heterocyclic amino acid or a deriv...
02/06/2007
7153873Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
Salts of a bicyclic, N-acylated imidazo-3-amine or an imidazo-5-amine of the formula: addition products thereof with acids, and methods for preparing the salts and addition products. Also disclosed are pharmaceut...
12/26/2006
7125863Inhibitors of dipeptidyl peptidase IV
Compounds according to formula (1), wherein R1 is H or CN, X1 is S, O, SO2 or CH2, X2 is CO, CH2 or a covalent bond, Het is a nitrogen-containing heterocycle and n is 1–5 are new. The compounds of t...
10/24/2006
71055502,4-disubstituted thiazolyl derivatives
This invention concerns the use of a compound of formula (I′) a N-oxide, pharmaceutically acceptable addition salt, quaternary amine and stereochemically isomeric form thereof, wherein Q is optionally substitut...
09/12/2006
7087626Pyrrole derivatives as pharmaceutical agents
Novel pyrrazole derivative compounds and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors. The disclosed invention relates to compounds of the structure (I) wherein (I) is a four, five, or six membered saturated ...
08/08/2006
7084137Thiazines and thiazoles as agents for protecting materials
The novel and known thiazines and thiazoles of the formula (I) in which R1, R2 and n are as defined in the description, are highly suitable for use as biocides for protecting in...
08/01/2006
7041694Cyclooxygenase-2 inhibition
Selective inhibitors of cyclooxygenase-2 are used to treat liver disease and in combination with anti-viral drugs to treat virus-caused liver disorders. Selective inhibitors of cyclooxygenase-2 which also inhibit the synthesis of cyclooxygenase-2 improve over the ef...
05/09/2006
7022701Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor. ...
04/04/2006
7012087p53 inhibitors and therapeutic use of the same
The therapeutic use of temporary p53 inhibitors in the treatment of p53-mediated diseases, conditions, and injuries is disclosed. ...
03/14/2006
7008957Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments
The invention relates to compounds of the formula I in which the radicals have the stated meanings, their stereoisomeric forms and their physiologically tolerated salts and process for their preparation. The com...
03/07/2006
6962914Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds
The present invention provides compounds of formula (I): pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents. ...
11/08/2005
6900160Triazolo-epothilones
The invention relates to triazolo-thiazole analogues of epothilone A and epothilone B. ...
05/31/2005
6875765Arylsulfonamide ethers, and methods of use thereof
The novel arylsulfonamide ether compounds, pharmaceutical compositions and uses thereof as inhibitors of interleukin-1β converting enzyme and other cysteine proteases in the ICE family are described. In one embodiment, the compound is described by the generalized s...
04/05/2005
6838462Insecticidal azoles
The present invention relates to novel heterocyclic compounds of formula (I) where A, R1, R2, Y, Z, and n are defined in the disclosure, to processes for their preparation, and to their use as crop protection agents, i...
01/04/2005
6821993Triazepine derivatives as neurotrophic agents
This invention relates to a series of triazepines of Formula I and II, and pharmaceutical compositions containing them. The compounds of the invention have neurotrophic activity and are useful in the treatment and prev...
11/23/2004
6794359Vertebrate intestinal protein which absorbs cholesterol, its inhibitors and mehtod of identifying the same
The invention relates to a vertebrate intestinal protein which absorbs cholesterol. It was possible to identify the protein by means of high-affinity crosslinking compounds. The invention further relates to this use of the protein for carrying out a method for ident...
09/21/2004
6770642Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor. ...
08/03/2004
6730686Methods for inhibiting oxidative modification of proteins
The instant invention provides compositions and methods for modeling post-Amadori AGE formation and the identification and characterization of effective inhibitors of post-Amadori AGE formation, and such identified inhibitor compositions. The instant invention also ...
05/04/2004
6696441Inhibition of p53-induced stress response
The present invention provides compounds that act to suppress p53 activity in mammalian cells, and a method to effectively suppress p53 activity in the cells of a mammal subject to a stress or pathology that is ameliorated by such suppression....
02/24/2004
6670128Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies
The present invention provide methods for utilizing spent leukodepletion filter devices as a source of material for the isolation and analysis of genomic DNA (gDNA), including polymorphism, genotyping, and pharmacogenomic studies. Cellular retentate with ...
12/30/2003
6586426ଲ-sheet mimetics and use thereof as protease inhibitors
There are disclosed ଲ-sheet mimetics and methods relating to the same for imparting or stabilizing the ଲ-sheet structure of a peptide, protein or molecule. In one aspect, the ଲ-sheet mimetics are covalently attached at the end or within ...
07/01/2003
6586419Phototherapeutic inactivation of ocular viruses
A method for inactivating ocular viral pathogens and for treating associated lesions on tissue by means of selectively activating a tissue-associated photosensitizing agent with light. The photosensitizing agent, preferably tin ethyl etiopurpurin, is admi...
07/01/2003
6586452C1 to C4 side chain modified nodulisporic acid analogs
The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents....
07/01/2003
6440963Use of selective COX-2 inhibitors for the treatment of urinary incontinence
The treatment of neuromuscular dysfunction of the lower urinary tract by compounds which selectively inhibit the COX-2 isozyme is described. The compounds concerned inhibit the COX-2 isozyme with a potency at least 10-fold, and preferably at least 100-fol...
08/27/2002
6395724Multibinding inhibitors of cyclooxygenase-2
Disclosed are multibinding compounds which inhibit cyclooxygenase-2 (COX-2), an enzyme which catalyzes the first committed step in the biosynthesis of prostaglandins. The multibinding compounds of this invention containing from 2 to 10 ligands covalently ...
05/28/2002
6380228Inhibitors of prenyl-protein transferase
The present invention is directed to peptidomimetic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this inv...
04/30/2002
6362191Aminometyl oxooxazolidinyl benzene derivatives
The invention concerns compounds of formula (I), ##STR1## wherein: A is a 5 membered heteroaryl ring, a bicyclic benzo system containing such a 5 membered heteroaryl ring or a bicyclic or tricyclic heteroaryl ring system with at least one bridgehead nitro...
03/26/2002
1        
 
Sign InRegister
Username  
Password   
forgot password?